Print

Lay Description

This study investigates whether an experimental medication is effective in slowing the progression of preclinical Alzheimer’s Disease in individuals with mild symptoms with or without a family history of AD.

Category

  • Healthy Subjects Needed
  • Aging and Geriatric
  • Diagnostic
  • Family Health
  • Nervous System
IRB Number
20200461HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
Between 55 and 80
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

Participants must have a study partner who is willing to provide information about the individual’s daily activities. ???????

Exclusion Criteria

Recent history of stroke, seizures, or major psychiatric illness. Inability to complete MRI scans.

Study Design

Arm Groups

Study Contact


Regulatory Point of Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu

Regulatory Point of Contact
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu

Regulatory Point of Contact
Eduardo Marques Zilli
(210) 450-8437
marqueszilli@uthscsa.edu

Local Recruitment Point of Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu

Local Recruitment Point of Contact
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu

Principal Investigator
Eduardo Marques Zilli